Mitochondrial involvement in amyotrophic lateral sclerosis

Neurochemistry International

Volumn 40, Issue 6, 2002, Pages 543-551

  Menzies, Fiona M ^a   Ince, Paul G ^b   Shaw, Pamela J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Electron transfer chain; Excitotoxicity; Mitochondria; Neurodegeneration; Oxidative stress; Superoxide dismutase

Indexed keywords

FREE RADICAL; SUPEROXIDE DISMUTASE;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN MITOCHONDRION; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL ULTRASTRUCTURE; CLINICAL FEATURE; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; GENE MUTATION; GENOME; HUMAN; HYPOTHESIS; MITOCHONDRIAL ENERGY TRANSFER; MOTONEURON; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; HOMEOSTASIS; HUMANS; MITOCHONDRIA;

EID: 0036176613     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00125-5     Document Type: Article

References (71)

1. Ultrastructure of atrophic muscle in amyotrophic lateral sclerosis
2. The ultrastructure of intramuscular nerves in amyotrophic lateral sclerosis
3. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases
4. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
5. ALS, SOD and peroxynitrite
6. Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclerosis
7. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death
8. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis
9. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis
10. 2+ concentration in transfected neuroblastoma SH-SY5Y cells
11. Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits
12. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease
13. Oxidative stress and motor neuron disease
14. Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age
15. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite
16. Amyotrophic lateral sclerosis: Oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes
17. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS)
18. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase
19. Mitochondrial DNA deletion mutation levels are elevated in ALS brains
20. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS
21. +: Implications for neurodegeneration
22. Mitochondrial free radical production and oxidative pathophysiology: Implications for neurodegenerative disease
23. Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis
24. Absence of electron transport (rho 0 state) restores growth of a manganese superoxide dismutase-deficient Saccharomyces cerevisiae in hyperoxia. Evidence for electron transport as a major source of superoxide generation in vivo
25. Motor neuron degeneration in mice that express a human Cu/Zn, superoxide dismutase mutation
26. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis
27. Parvalbumin and calbindin D-28 k in the human motor system and in motor neuron disease
28. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateralsclerosis-linked SOD1 mutations
29. Chronic mitochondrial inhibition induces selective motoneuron death in vitro: A new model for amyotrophic lateral sclerosis
30. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
31. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1
32. Mitochondrial control of cell death
33. ALS-linked Cu/Zn SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis
34. CuZn SOD and Mn SOD immunoreactivity in brain stem motor neurons from amyotrophic lateral sclerosis patients
35. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
36. Manganese, superoxide dismutase levels are elevated in a proportion of amyotrophic lateral sclerosis patient cell lines
37. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
38. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu, Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease
39. Peroxynitrite: A biologically significant oxidant
40. Mitochondria in neurodegeneration: Bioenergetic function in cell life and death
41. Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis
42. Axonal swellings in the corticospinal tracts in amyotrophic lateral sclerosis
43. Brain glutamate deficiency in amyotrophic lateral sclerosis
44. 4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites
45. Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: Correlation between genotype and clinical features
46. Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex
47. Normal oxidative damage to mitochondrial and nuclear DNA is extensive
48. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis
49. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
50. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis
51. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis
52. Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis
53. Glutamate, excitotoxicity and amyotrophic lateral sclerosis
54. CSF and plasma amino acid levels in motor neuron disease: Elevation of CSF glutamate in a subset of patients
55. Oxidative damage to protein in sporadic motor neuron disease spinal cord
56. Immunocytochemical study of the distribution of the free radical scavenging enzymes Cu/Zn superoxide dismutase (SOD1); MN superoxide dismutase (Mn SOD) and catalase in the normal human spinal cord and in motor neuron disease
57. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis
58. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis
59. A fraction of yeast Cu/Zn superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria: A physiological role for SOD1 in guarding against mitochondrial oxidative damage
60. Mitochondria in sporadic amyotrophic lateral sclerosis
61. Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS
62. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis
63. An immunohistochemical study of the neuronal expression of manganese superoxide dismutase in sporadic amyotrophic lateral sclerosis
64. Mitochondrial genetics: A paradigm for aging and degenerative diseases
65. Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice
66. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis
67. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis
68. An immunocytochemical study of the distribution of AMPA selective glutamate receptor subunits in the normal human motor system
69. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
70. Inactivation of human manganese superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine
71. Liver, mitochondrial respiratory functions decline with age